Glaucoma refers to a group of eye conditions that can gradually make you lose some or all of your eyesight. Glaucoma develops ...

More than 3 million people in the U.S. are estimated to be living with glaucoma. By 2030, that number is expected to increase by 58% to more than 4.2 million people. Glaucoma is an eye disease ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

You may have heard the term “glaucoma” before, but what is it really, and how do you know if you have it? Glaucoma is an eye disease in which the optic nerve is damaged over time due to elevated ...

Glaucoma creeps in without pain or obvious symptoms, slowly damaging your optic nerve. Regular eye exams and early detection ...

Open-angle glaucoma is an eye disease that causes a gradual loss of vision. It is the most common type of glaucoma, a set of eye diseases that affect the eye's optic nerve. The optic nerve is located ...

There is currently no way to prevent glaucoma. However, by undergoing regular eye exams, taking medications, and maintaining beneficial lifestyle habits, a person can reduce the risk of vision loss ...

Many people casually dismiss occasional blurry vision as simple eye fatigue or the need for new glasses. However, eye health specialists caution that this common symptom deserves serious attention, ...

SIOUX FALLS, SD – November 04, 2025 – PRESSADVANTAGE – Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred.

Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...

Moran Eye Center Glaucoma Research Fellow Michael Jensen, MD, holds an iCare HOME2 device that glaucoma patients can use at home to measure eye pressure. Glaucoma is an incurable, insidious eye ...

Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.